Letter to the editor: 'Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America'

被引:2
|
作者
Novaes, Romulo Dias [1 ]
Goncalves, Reggiani Vilela [2 ]
机构
[1] Univ Fed Alfenas, Inst Biomed Sci, Dept Struct Biol, Alfenas, Brazil
[2] Univ Fed Vicosa, Ctr Biol & Hlth Sci, Dept Anim Biol, Vicosa, MG, Brazil
关键词
American trypanosomiasis; anti-infective therapy; diagnostic methods; parasitology; Trypanosoma cruzi; TRYPANOSOMA-CRUZI INFECTION; RANDOMIZED-TRIAL; BENZNIDAZOLE; POSACONAZOLE;
D O I
10.1080/14787210.2019.1649140
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:671 / 672
页数:2
相关论文
共 50 条
  • [31] IgG Subclass Analysis in Patients with Chagas Disease 4 Years After Benznidazole Treatment
    Llaguno, Mauricio
    da Silva, Marcos Vinicius
    Helmo, Fernanda Rodrigues
    Batista, Lara Rocha
    Alves da Silva, Djalma Alexandre
    de Sousa, Rodrigo Cunha
    Pertili Rodrigues de Resende, Luiz Antonio
    Lages-Silva, Eliane
    Freire Oliveira, Carlo Jose
    Machado, Juliana Reis
    Rocha Rodrigues, Denise Bertulucci
    Correia, Dalmo
    Rodrigues, Virmondes
    ACTA PARASITOLOGICA, 2021, 66 (04) : 1499 - 1509
  • [32] Vector distribution of Chagas Disease in "non-endemic" countries: the possibility of vector transmission outside Latin America
    Schofield, Chris J.
    Grijalva, Mario J.
    Diotaiuti, Lileia
    ENFERMEDADES EMERGENTES, 2009, 11 : 20 - 27
  • [33] A scoping review of triatomine control for Chagas disease prevention: current and developing tools in Latin America and the United States
    Tian, Yuexun
    Durden, Cassandra
    Hamer, Gabriel L.
    JOURNAL OF MEDICAL ENTOMOLOGY, 2024, 61 (06) : 1290 - 1308
  • [34] New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease
    Fonseca Murta, Silvane Maria
    Lemos Santana, Pedro Augusto
    Jacques Dit Lapierre, Thibault Joseph William
    Penteado, Andre Berndt
    El Hajje, Marissa
    Navarro Vinha, Thabata Corazza
    Liarte, Daniel Barbosa
    de Souza, Mariana Laureano
    Goulart Trossini, Gustavo Henrique
    de Oliveira Rezende Junior, Celso
    de Oliveira, Renata Barbosa
    Ferreira, Rafaela Salgado
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (06) : 741 - 753
  • [35] Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment
    Queiroz-Telles, Flavio
    Nucci, Marcio
    Colombo, Arnaldo Lopes
    Tobon, Angela
    Restrepo, Angela
    MEDICAL MYCOLOGY, 2011, 49 (03) : 225 - 236
  • [36] Eco-bio-social research on community-based approaches for Chagas disease vector control in Latin America
    Guertler, Ricardo E.
    Yadon, Zaida E.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2015, 109 (02) : 91 - 98
  • [37] Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail
    Crespillo-Andujar, C.
    Chamorro-Tojeiro, S.
    Norman, F.
    Monge-Maillo, B.
    Lopez-Velez, R.
    Perez-Molina, J. A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (12) : 1344.e1 - 1344.e4
  • [38] A deadly feast: Elucidating the burden of orally acquired acute Chagas disease in Latin America - Public health and travel medicine importance
    Franco-Paredes, Carlos
    Villamil-Gomez, Wilmer E.
    Schultz, Jonathan
    Henao-Martinez, Andres F.
    Parra-Henao, Gabriel
    Rassi Jr, Anis
    Rodriguez-Morales, Alfonso J.
    Antonio Suarez, Jose
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 36
  • [39] TO TREAT OR NOT TO TREAT? SCIENTIFIC CONTROVERSY ABOUT THE TREATMENT FOR CHRONIC CHAGAS' DISEASE PATIENTS
    Kreimer, Pablo
    Ana Romero, Lucia
    Bilder, Paula
    ASCLEPIO-REVISTA DE HISTORIA DE LA MEDICINA Y DE LA CIENCIA, 2010, 62 (02) : 405 - 427
  • [40] Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment
    Santamaria, Cynthia
    Chatelain, Eric
    Jackson, Yves
    Miao, Qianqian
    Ward, Brian J.
    Chappuis, Francois
    Ndao, Momar
    BMC INFECTIOUS DISEASES, 2014, 14